SEC Comment Letter 0000000000-24-000627 to Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070) (NEUP)
Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070)
Date: Jan. 18, 2024 · CIK: 0001191070 · Accession: 0000000000-24-000627
AI Filing Summary & Sentiment
File numbers found in text: 001-41157
Letter
United States securities and exchange commission logo January 18, 2024 Timothy Cunningham Chief Financial Officer Bionomics Limited 200 Greenhill Road Eastwood SA 5063 Australia Re:Bionomics Limited Form 20-F for the Fiscal Year Ended June 30, 2023 Filed October 18, 2023 File No. 001-41157 Dear Timothy Cunningham: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
January 18, 2024
Timothy Cunningham
Chief Financial Officer
Bionomics Limited
200 Greenhill Road
Eastwood SA 5063
Australia
Re:Bionomics Limited
Form 20-F for the Fiscal Year Ended June 30, 2023
Filed October 18, 2023
File No. 001-41157
Dear Timothy Cunningham:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences